Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 2,761 shares at $299.88 ($828K) on 2020-10-29, disclosed to the SEC on 2020-11-02.
Seasonal sale ($828k) by CMO, Hematology — this insider has traded BGNE in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $299.88 | 1,261 | $378K | 45.7% |
| 2 | $299.88 | 1,261 | $378K | 45.7% |
| 3 | $300.70 | 139 | $42K | 5.0% |
| 4 | $301.51 | 100 | $30K | 3.6% |
| Total | $299.98 avg | 2,761 | $828K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |